Meda Pharmaceuticals has launched Edluar (zolpidem tartrate sublingual tablets) for the short-term treatment of insomnia characterized by difficulties falling asleep.
Edluar is a C-IV controlled drug. It is available in 5mg and 10mg dosage strengths.
For more information call (732) 564-2200 or visit www.edluar.com.
Related Content